Investigation Launched by Pomerantz LLP Regarding Profound Medical Corp.
New York, NY – March 27, 2025
Pomerantz LLP, a leading securities law firm, is investigating claims on behalf of investors of Profound Medical Corp. (“Profound” or the “Company”) (NASDAQ: PROF). Those who purchased or otherwise acquired Profound securities between [Date 1] and [Date 2] are encouraged to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 125 for information about this class action investigation.
Background
Profound Medical Corp. is a medical device company that specializes in the commercialization and development of therapeutic applications of magnetic resonance imaging (“MRI”)-guided focused ultrasound. The Company’s TULSA-PRO system is designed to provide precise, image-guided, and incision-free ablation of soft tissue, including prostate tissue.
Allegations
The investigation concerns whether Profound and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. Specifically, it is alleged that Profound made materially false and misleading statements regarding the commercial success of its TULSA-PRO system.
Impact on Individual Investors
If you purchased or otherwise acquired Profound securities during the relevant period and suffered a loss, you may be eligible to recover your damages. Investors who wish to learn more about the investigation or their legal rights are encouraged to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 125.
Global Implications
The investigation of Profound Medical Corp. could have far-reaching implications for the medical device industry as a whole. If it is found that the Company and its executives misrepresented the commercial success of the TULSA-PRO system, it could lead to increased scrutiny of other companies in the sector. Additionally, it could potentially deter investors from putting their trust and money into medical device companies, leading to a decrease in funding for research and development.
Conclusion
The investigation into Profound Medical Corp. by Pomerantz LLP is a significant development for investors who purchased or otherwise acquired the Company’s securities during the relevant period. It is important for these individuals to understand their legal rights and potential remedies. Furthermore, the potential implications for the medical device industry as a whole cannot be ignored.
- Investors who purchased Profound securities between [Date 1] and [Date 2] should contact Danielle Peyton at [email protected] or 646-581-9980, ext. 125 for more information about the investigation.
- The investigation could have far-reaching implications for the medical device industry as a whole.
- Individuals who suffered losses as a result of purchasing Profound securities during the relevant period may be eligible to recover their damages.
